Virtu Financial LLC Zai Lab LTD Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$34.2 - $51.69 $497,404 - $751,779	14,544 New	14,544 $497,000
Q4 2021 Feb 17, 2022	SELL	$54.9 - $105.21 $266,319 - $510,373	-4,851 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $362,880 - $616,446	3,456 Added 247.74%	4,851 $511,000
Q2 2021 Sep 17, 2021	BUY	$125.11 - $180.0 $174,528 - $251,100	1,395 New	1,395 $247,000
Q3 2020 Dec 11, 2020	SELL	$73.3 - $89.48 $603,185 - $736,330	-8,229 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$48.82 - $82.53 $401,739 - $679,139	8,229 New	8,229 $676,000
Q4 2017 Feb 09, 2018	SELL	$21.23 - $34.09 $204,763 - $328,798	-9,645 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$27.0 - $31.11 $260,415 - $300,055	9,645	9,645 $260,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.